Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Nephrology
Published in: Journal of Nephrology 4/2017

01-08-2017 | Review

The conundrums of chronic kidney disease and aging

Authors: Richard J. Glassock, Aleksandar Denic, Andrew D. Rule

Published in: Journal of Nephrology | Issue 4/2017

Login to get access

Abstract

Chronic kidney disease (CKD), as presently defined, is a common disorder. Aging is a nearly universal phenomenon that can affect renal anatomy and function, but at variable rates in individuals. Loss of nephrons and a decline in glomerular filtration rate (GFR) is a characteristic of normal aging, called renal senescence. Using fixed and absolute thresholds for defining CKD on the basis of GFR for all ages may lead to diagnostic uncertainty (a conundrum) in both young and older subjects. This brief review will consider the physiological and anatomical changes of the kidney occurring in the process of normal renal senescence focusing on GFR and will examine the relevance of these observation for the diagnosis of CKD using GFR as the distinguishing parameter. Once a better understanding of the pathobiology underlying renal senescence is obtained, specific interventions may become available to slow the process.
Literature
1.
Glassock RJ, Warnock D, Delanaye P (2016) The Global burden of CKD. Nat Rev Nephrol (in press)
2.
Martinez DE (1998) Mortality patterns suggest lack of senescence in hydra. Exp Gerontol 33(3):217–225CrossRefPubMed
3.
Finch CE, Kirkwood TBL (2000) Chance, development and aging, 1st edn. Oxford University Press, New York
4.
5.
Schlanger L (2009) Kidney senescence. In: Geriatric nephrology curriculum. American Society of Nephrology
6.
Klenk J et al (2016) Changes in life expectancy 1950–2010: contributions from age- and disease-specific mortality in selected countries. Popul Health Metr 14:20CrossRefPubMedPubMedCentral
7.
8.
Ebert N, Jakob O, Gaedeke J, van der Giet M, Kuhlmann MK, Martus P, Mielke N, Schuchardt M, Tölle M, Wenning V, Schaeffner ES (2016) Prevalence of reduced kidney functionand albuminuria in older adults: the Berlin Initiative Study. Nephrol Dial Transplant (Epub ahead of print)
9.
Wetzels JF, Kiemeney LA, Swinkels DW, Willems HL, den Heijer M (2007) Age- and gender-specific reference values of estimated GFR in Caucasians: the Nijmegen Biomedical Study. Kidney Int 72:632–637CrossRefPubMed
10.
Lindeman RD, Tobin J, Shock NW (1985) Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc 33:278–285CrossRefPubMed
11.
Lindeman RD, J.D. To bin, Shock NW (1984) Association between blood pressure and the rate of decline in renal function with age. Kidney Int 26:861–868CrossRefPubMed
12.
Hollenberg NK et al (1999) Age, renal perfusion and function in island-dwelling indigenous Kuna Amerinds of Panama. Nephron 82:131–138CrossRefPubMed
13.
Epstein M (1996) Aging and the kidney. J Am Soc Nephrol 7:1106–1122PubMed
14.
Glassock RJ, Rule AD (2015) The kidney in aging. In: Davison AM et al (eds) Oxford textbook of clinical nephrology. Oxford University Press, Oxford
15.
Cohen E, Nardi Y, Krause I et al (2014) A longitudinall assesment of the natural rate of decline of renal function with age. J Nephrol 27:635–641CrossRefPubMed
16.
Hoang K et al (2003) Determinants of glomerular hypofiltration in aging humans. Kidney Int 64:1417–1424CrossRefPubMed
17.
18.
Glassock RJ, Rule AD (2012) The implications of anatomical and functional changes of the aging kidney: with an emphasis on the glomeruli. Kidney Int 82:270–277CrossRefPubMedPubMedCentral
19.
20.
Elsherbiny HE et al (2014) Nephron hypertrophy and glomerulosclerosis and their association with kidney function and risk factors among living kidney donors. Clin J Am Soc Nephrol 9:1892–1902CrossRefPubMedPubMedCentral
21.
Wang X et al (2014) Age, kidney function, and risk factors associate differently with cortical and medullary volumes of the kidney. Kidney Int 85:677–685CrossRefPubMed
22.
Denic A et al (2016) Detection and clinical patterns of nephron hypertrophy and nephrosclerosis among apparently healthy adults. Am J Kidney Dis 68:58–67CrossRefPubMedPubMedCentral
23.
Denic A et al (2016) The substantial loss of nephrons in healthy human kidneys with aging. J Am Soc Nephrol (Epub ahead of print)
24.
25.
Denic A et al (2015) Clinical characteristics associate differently with single nephron GFR than total GFR in normal adults. J Am Soc Nephrol (Abstract, in preparation)
26.
Brenner BM, Meyer TW, Hostetter TH (1982) Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N Engl J Med 307:652–659CrossRefPubMed
27.
Olson JL et al (1982) Altered glomerular permselectivity and progressive sclerosis following extreme ablation of renal mass. Kidney Int 22:112–126CrossRefPubMed
28.
Hostetter TH et al (2001) Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. J Am Soc Nephrol 12:1315–1325PubMed
29.
Brenner BM (1985) Nephron adaptation to renal injury or ablation. Am J Physiol Renal Physiol 249:F324–F337
30.
Risdon RA, Sloper JC, de Wardener HE (1968) Relationship between renal function and histological changes found in renal biopsy specimens from patients with persistent glomerular nephritis. Lancet 2:363–366CrossRefPubMed
31.
Thomas SE, Anderson S, Gordon KL, Oyama TT, Shankland SJ, Johnson RJ (1998) Tubulointerstitial disase in aging: evidence for underlying peritubular capillary damage, a potential role for glomerular ischemia. J Am Soc Nephrol 9:231–242PubMed
32.
33.
Luyckx VA, Brenner BM (2015) Birth weight, malnutrition and kidney-associated outcomes—a global concern. Nat Rev Nephrol 11:135–139rCrossRefPubMed
34.
Kidney Disease Outcome Quality Initiative (K/DOQI) (2002) Clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39(Suppl 2):S1–S246
35.
Glassock R, Delanaye P, El Nahas M (2015) An age-calibrated classification of chronic kidney disease. JAMA 314:559–560CrossRefPubMed
36.
37.
38.
Coresh J et al (2014) Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality. JAMA 311:2518–2531CrossRefPubMedPubMedCentral
39.
Chronic Kidney Disease Prognosis Consortium et al (2010) Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 375:2073–2081CrossRef
40.
Astor BC et al (2011) Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts. Kidney Int 79:1331–1340CrossRefPubMed
41.
Gansevoort RT et al (2011) Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts. Kidney Int 80:93–104CrossRefPubMedPubMedCentral
42.
van der Velde M et al (2011) Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. Kidney Int 79:1341–1352CrossRefPubMed
43.
Coca SG, Singanamala S, Parikh CR (2012) Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. Kidney Int 81:442–448CrossRefPubMed
44.
45.
Gansevoort RT et al (2013) Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet 382:339–352CrossRefPubMed
46.
O’Hare AM et al (2014) Interpreting treatment effects from clinical trials in the context of real-world risk information: end-stage renal disease prevention in older adults. JAMA Intern Med 174:391–397CrossRefPubMedPubMedCentral
47.
Delanaye P et al (2016) An age-calibrated definition of chronic kidney disease: rationale and benefits. Clin Biochem Rev 37:17–26PubMedPubMedCentral
48.
Pottel H, Hoste L, Delanaye P (2015) Abnormal glomerular filtration rate in children, adolescents and young adults starts below 75 mL/min/1.73 m2. Pediatr Nephrol 30:821–828CrossRefPubMed
49.
Perrone RD, Madias NE, Levey AS (1992) Serum creatinine as an index of renal function: new insights into old concepts. Clin Chem 38:1933–1953PubMed
50.
51.
Delanaye P, Mariat C (2013) The applicability of eGFR equations to different populations. Nat Rev Nephrol 9:513–522CrossRefPubMed
52.
53.
Schaeffner ES et al (2012) Two novel equations to estimate kidney function in persons aged 70 years or older. Ann Intern Med 157:471–481CrossRefPubMed
54.
Pottel H, Hoste L, Dubourg L, Ebert N, Schaeffner E, Eriksen BO, Melsom T, Lamb EJ, Rule AD, Turner ST, Glassock RJ, De Souza V, Selistre L, Mariat C, Martens F, Delanaye P (2016) An estimated glomerular filtration rate equation for the full age spectrum. Nephrol Dial Transplant 31:798–806CrossRefPubMedPubMedCentral
55.
Gharbi MB, Elseviers M, Zamd M, Alaoui AB, Benahadi N, Trabelssi EH, Bayahai R, Ramdani B, De Broe ME (2016) Chronic kidney disease, hypertension, diabetes and obesity in the adult population of Morocco: how to avoid “over"- and “under"- diagnosis of CKD. Kidney Int 89:1363–1371CrossRef
56.
Singh, AK, Raed A, Kari J (2015) Endocrine complications of chronic kidney disease. In: Kimmel PL, Rosenberg ME (eds) Chronic renal disease. Academic Press, San Diego, pp 310–319
57.
Malmgren L, McGuigan FE, Berglundh S, Westman K, Christensson A, Åkesson K (2015) Declining estimated glomerular filtration rate and its association with mortality and comorbidity over 10 years in elderly women. Nephron 130:245–255CrossRefPubMed
58.
Delanaye P, Glassock RJ (2015) Glomerular filtration rate and aging: another longitudinal study—A long time coming! Nephron 131:1–4CrossRefPubMed
59.
Dalrymple LS et al (2011) Chronic kidney disease and the risk of end-stage renal disease versus death. J Gen Intern Med 26:379–385CrossRefPubMed
60.
Sud M et al (2014) Risk of end-stage renal disease and death after cardiovascular events in chronic kidney disease. Circulation 130:458–465CrossRefPubMed
61.
Kasiske BL, Kumar R, Kimmel PL, Pesavento TE, Kalil RS, Kraus ES, Rabb H, Posselt AM, Anderson-Haag TL, Steffes MW, Israni AK, Snyder JJ, Singh RJ, Weir MR (2016) Abnormalities in biomarkers of mineral and bone metabolism in kidney donors. Kidney Int (Epub ahead of print)
62.
Gansevoort RT, de Jong PE (2010) Challenges for the present CKD classification system. Curr Opin Nephrol Hypertens 19:308–314CrossRefPubMed
63.
Hudson JQ, Bean JR, Burger CF, Stephens AK, McFarland MS (2015) Estimated glomerular filtration rate leads to higher drug dose recommendations in the elderly compared with creatinine clearance. Int J Clin Pract 69:313–320CrossRefPubMed
64.
Ocampo A, Reddy P, Izpisua Belmonte JC (2016) Anti-aging strategies based on cellular reprogramming. Trends Mol Med 22:725–738CrossRefPubMed
65.
66.
Glassock RJ, Rule AD (2016) The kidney in aging: biology, anatomy, physiology and clinical relevance. In: Turner N et al (eds) Oxford textbook of clinical nephrology. Oxford University Press, Oxford
67.
Boubred F et al (2007) Effects of early postnatal hypernutrition on nephron number and long-term renal function and structure in rats. Am J Physiol Renal Physiol 293:F1944–F1949CrossRefPubMed
68.
Brenner BM, Mackenzie HS (1997) Nephron mass as a risk factor for progression of renal disease. Kidney Int Suppl 63:S124–S127PubMed
69.
Wlodek ME et al (2007) Normal lactational environment restores nephron endowment and prevents hypertension after placental restriction in the rat. J Am Soc Nephrol 18:1688–1696CrossRefPubMed
70.
Chin MP et al (2014) Risk factors for heart failure in patients with type 2 diabetes mellitus and stage 4 chronic kidney disease treated with bardoxolone methyl. J Card Fail 20:953–958CrossRefPubMed
71.
72.
Boubred F et al (2016) High protein intake in neonatal period induces glomerular hypertrophy and sclerosis in adulthood in rats born with IUGR. Pediatr Res 79:22–26CrossRefPubMed
73.
Eriksen BO et al (2016) Elevated blood pressure is not associated with accelerated glomerular filtration rate decline in the general non-diabetic middle-aged population. Kidney Int 90:404–410CrossRefPubMed
74.
75.
Freedman BI (2013) APOL1 and nephropathy progression in populations of African ancestry. Semin Nephrol 33:425–432CrossRefPubMed
76.
Larsen CP et al (2015) Histopathologic findings associated with APOL1 risk variants in chronic kidney disease. Mod Pathol 28:95–102CrossRefPubMed
77.
Luyckx VA, Bertram JF, Brenner BM, Fall C, Hoy WE, Ozanne SE, Vikse BE (2013) Effect of fetal and child health on kidney development and long-term risk of hypertension and kidney disease. Lancet 382:273–283CrossRefPubMed
78.
Luyckx VA, Shukha K, Brenner BM (2011) Low nephron number and its clinical consequences. Rambam Maimonides Med J 31:e0061CrossRef
Metadata
Title
The conundrums of chronic kidney disease and aging
Authors
Richard J. Glassock
Aleksandar Denic
Andrew D. Rule
Publication date
01-08-2017
Publisher
Springer International Publishing
Published in
Journal of Nephrology / Issue 4/2017
Print ISSN: 1121-8428
Electronic ISSN: 1724-6059
DOI
https://doi.org/10.1007/s40620-016-0362-x

Other articles of this Issue 4/2017

Journal of Nephrology 4/2017 Go to the issue

Review

Intravenous fluids: balancing solutions

Original Article

Effect of oral anticoagulant therapy on mortality in end-stage renal disease patients with atrial fibrillation: a prospective study

Original Article

The duration of acute kidney injury after cardiac surgery increases the risk of long-term chronic kidney disease

Original Article

Incremental start to PD as experienced in Italy: results of censuses carried out from 2005 to 2014

Erratum

Erratum to: A best practice position statement on pregnancy in chronic kidney disease: the Italian Study Group on Kidney and Pregnancy

Original Article

Treatment for non-thyroidal illness syndrome in advanced chronic kidney disease: a single-blind controlled study
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits